The following is a collection of
featured thoracic articles from the Journal of Thoracic and Cardiovascular
Surgery (JTCVS). To read the latest issue, or
browse the feature video library and other journal
highlights, please visit www.jtcvs.org.
Please add firstname.lastname@example.org to your
Safe Senders list.
prospective, observational study of a novel technique for
preoperative pulmonary nodule localization
Liwen Fan, MD, PhD, Haitang Yang,
MD, PhD, LingMing Yu, MD, Zhexin Wang, MD, Jianding Ye,
MD, Yang Zhao, MD, Deng Cai, MD, PhD, Heng Zhao, MD,
Feng Yao, MD
anchor with scaled suture provides advantages for
thoracoscopic resection of small lung nodules. Our
prospective evaluation showed good success, safety,
feasibility, and tolerability.
Preoperative localization: Another tool in the box
L. Starnes, MD
A new percutaneous localization
device may ameliorate the disadvantages of the
traditional hookwire technique. This adds another
tool to the armamentarium of localization methods.
A new tool for solitary peripheral nodule
localization—Going beyond “good enough”
Gregor, MD, Kazuhiro Yasufuku, MD, PhD
A new hook-and-suture device was
safe and effective in localizing small SPNs ≤10 mm
in size without requiring intraoperative imaging.
One more way to skin the cat
Hanna, MDCM, MBA, FRCSC
The armamentarium of pulmonary
nodule localization is being enriched by new
techniques, and this is important for the evolution
of thoracic surgery.
Animated demo for the new localization
fluorodeoxyglucose–positron emission tomography/computed
tomography have a role in cervical nodal staging for
esophageal squamous cell carcinoma?
Bin Li, MD, Nan Li, MD, Shuoyan
Liu, MD, Yin Li, MD, Bin Qian, MD, Yawei Zhang, MD, Hao
He, MD, Xiankai Chen, MD, Yihua Sun, MD, Jiaqing Xiang,
MD, Hong Hu, MD, Haiquan Chen, MD
scanning exhibited high specificity but low sensitivity
in diagnosing cervical lymph node metastases of
esophageal cancer, indicating its limited value for
tomography/computed tomography for cervical adenopathy
in esophageal carcinoma, an option for the selective
In locally advanced esophageal
cancer, PET alone may be adequate for stage.
Patients who lack a PET or have early proximal
disease may benefit from neck ultrasound as an
alternative staging modality.
Esophageal squamous cell carcinoma: A disease requiring
Chen, MD, PhD
We should clearly note that PET/CT
in ESCC is not only limited to detecting LNM, and
the role of PET/CT in systemic staging is
Cervical lymph node dissection for
esophageal cancer after FDG-PET/CT.
analysis of open versus minimally invasive thymectomy for
stage I to III thymoma
Chi-Fu Jeffrey Yang, MD, Jacob
Hurd, Shivani A. Shah, BA, Douglas Liou, MD, Hanghang
Wang, MD, PhD, Leah M. Backhus, MD, Natalie S. Lui, MD,
Thomas A. D'Amico, MD, Joseph B. Shrager, MD, Mark F.
Berry, MD, MHS
national analysis, minimally invasive thymectomy was
associated with similar short-term outcomes and
intermediate-term survival when compared with open
thymectomy for stage I to III thymoma.
Minimally invasive versus open thymectomy for stage I
to III thymoma—Big incision, small difference?
E. Giles, MD, MPH, Nicholas LeBlanc, MD, Biniam
Kidane, MD, MSc
Minimally invasive thymectomy may be
an acceptable alternative to open thymectomy, but
longer follow-up is needed. Approach to stage III
thymoma should be dictated by the pattern of
Minimally-invasive thymectomy with minimal concerns
Taylor Ripley, MD
Minimally-invasive thymectomy is an
oncologically acceptable alternative to open
thymectomy for the resection of thymoma. Multiple
studies over nearly 3 decades do not support the
concern of increased tumor dissemination.
The impact of
change in definition of increased-risk donors on survival
after lung transplant
Carli J. Lehr, MD, MS, Rocio
Lopez, MS, Susana Arrigain, MA, Jesse Schold, PhD,
MStat, MEd, Christine Koval, MD, Maryam Valapour, MD,
risk definition update in 2013 increased the number of
donors classified as nonstandard risk. The use of
increased-risk donors expands the donor pool without
The changing face of risk management
K. Hayanga, MD, MPH, Ankit Dhamija, MD, J.W. Awori
Hayanga, MD, MPH
Using organs from increased-risk
donors does not jeopardize outcomes.
Innovation…or disruption and the delayed
acknowledgement of a new reality
A. Klapper, MD
Delayed acceptance in an era of
surgeons' insights: Improving thoracic surgery outcomes
during the Coronavirus Disease 2019 pandemic
Ke-Neng Chen, MD, Shugeng Gao, MD,
Lunxu Liu, MD, Jianxing He, MD, Ge-Ning Jiang, MD, Jie
surgery, enhancing comprehensive treatment, and
implementing strategies to prevent nosocomial COVID-19
infection will ensure medical safety and quality of
of coronavirus disease 2019 in 11 patients after thoracic
surgery and challenges in diagnosis
Shu Peng, MD, PhD, Liu Huang, MD,
Bo Zhao, MD, Shuchang Zhou, MD, Irene Braithwaite, MD,
PhD, Ni Zhang, MD, Xiangning Fu, MD
signs of COVID-19 were disguised in 11 postoperative
thoracic patients, resulting in a 27.3% fatality rate.
Challenges to thoracic surgeons in the global
Zhang, MD, Haiquan Chen, MD, PhD
The global pandemic of COVID-19
brings challenges to thoracic surgeons. It is
important to avoid unnecessary surgeries and to be
alert to the risk of COVID-19 infection following
Echoes of war
Rocco, MD, FRCSEd
Aggressive identification of
COVID-19 surgical candidates is mandatory to avoid
lethal postoperative complications and prevent
exposing surgeons to the contagion.
The double responsibility of the thoracic surgeon at
the time of the pandemic: A perspective from the North
Scarci, MD, FRCS(Eng), FCCP, FACS, Federico Raveglia,
Insidious diagnosis and high
fatality rate of COVID-19 require special
management of patients referred to thoracic
surgery. Maximum in clinical surveillance and
preoperative selection are mandatory.
of patients infected with severe acute respiratory
syndrome coronavirus 2 soon after thoracoscopic lung
Jingyu Huang, MD, PhD, Aifen Wang,
MD, Ganjun Kang, MD, Dejia Li, PhD, Weidong Hu, MD, PhD
may be very high in patients who contract SARS-CoV-2
pneumonia after lung lobectomy. Lung surgery should be
performed with extreme caution in SARS-CoV-2 epidemic
Primum non nocere
J. Swanson, MD
Do not operate on elective thoracic
patients until the COVID-19 pandemic subsides.
Lung surgery in the time of COVID-19
Muñoz-Largacha, MD, Benjamin Wei, MD
Best practices for surgical patients
during the COVID-19 pandemic are not well
described. This study reports a 67% mortality rate
among 3 patients who contracted COVID-19 after